Gilead, Biotechs Gain Amid Market Rout on Virus Cure Hopes

(Bloomberg) -- Gilead Sciences Inc. gained the most among the trio of advancers in the S&P 500 Index Wednesday, climbing despite a market rout as investors focus on reports of patients getting the ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.